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Objectives . This study intended to evaluate application of
tanscatheter occlusion of the patent ductus arterteuus in children
<10 kg body weight.
Background
.
Tansatheter occlusion of the patent during
arteelaos to the child weighing >10 kg has been proved safe and
effective.
Methods . We reviewed 74 consecutive patients weighing
<10 kg (median 8.1 kg, range 3.90 to 10) and aged 4 to 30 meths
(median 13 mended who underwent patent ductus arlerleem octin-
siat between June 1986 and November 1992, A modification of tat
delivery system tofacWlale application In and children Is described .
Results . A 12-mm desire was implanted in 50 patients and a
17-mm device In 24. Three device embdiaatkaes occurred early In
the experience, and one required removal because of hemollysis
Transcatheter occlusion has been demonstrated to
be
a safe
and effective procedure for closure of the persistently patent
ductus artetiosus (1-5) . Although generally applied in children
> IO kg, the 8F and I 1 F delivery systems required for implan-
tation of the 12- and 17-mm devices, respectively, may limit
application of the technique in the smaller child . Recently
reported modifications to the delivery system could facilitate
application to otherwise eligible but smaller candidates for
transcatheter occlusion (6,7). This report presents ourexpe-
rience with device implantation in children <10 kg, details
modifications in the technique that allow use of a smaller
French-sized delivery system and underscores concern over
potential compromise to left pulmonary artery blood flow .
Methods
From June 1986 to November 1992, 74 of 345 patients
who underwent cardiac catheterization for occlusion of the
patent ductus arteriosus at the Hospital for Sick Children,
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associated with a moderate residual shunt. One 17-mm device was
removed at catheterlraf6o blame of acute compromise to left
pulmonary artery now after imptentatlen . Prevalence of residual
ehuaisg was 33% at 6 months, 20% at 12 to 18 months and 17%
at 2-year follow-up and was not related to device, age, weight or
size of the patent dada, Altered now to the left pubaanary money
was Noted In seven palkms (9,9%), with more significant com.
Promise antedated with the 17-mm device .
Coaelssiour
. Tramcnhefer patent ductus aetmimas occlusion
is feasible in the small child <10 kg, Particularly with the on of a
modified delivery system. However, hnploOHlas of a 17-mm
device ha this patient population my Impair now to the left lung
and mount be reserved for the
symptom*
child.
(J An, Call CardIai 1894;23:1666-70)
Toronto, weighed < 10 kg at the time of the procedure . All
patients underwent complete clinical examination, including
echocardiogaphic investigation. and informed parental con-
sent was obtained before device implantation. At the time of
cathelerization, aortogaphy demonstrated the size and
morphology of the ductus arteriosus. The size of the patent
ductus arteriosus was measured at the narrowest point using
electronic calipers with the magnifactien factor calculated
from the catheter diameter. Auscultation for the presence
and character of a murmur was recorded following the
procedure ; however, patients were not subjected to routine
aortogaphy or echocardiography before discharge. Patient
records were reviewed with attention to associated cardiac
lesions, presence of a murmur and echocardiogaphic evi-
dence of a residual shunt across the patent ductus arteriosus
using established technique (8) at 6 . 12 to 18 and 24 months
after implantation .
Details of standard device implantation (Bard PDA Um-
brella Device, USCI Angiographics) have been published
elsewhere (2,3,9) . Femoral venous implantation technique
was used exclusively . In eight patients, loading and delivery
of the device was modified to allow the use of a smaller
delivery system (6F and SF for the 12- and the 17-mm
devices, respectively). The delivery catheter (USCI Angio-
graphics) was modified by stripping the external catheter
material from the central wire, thus freeing the metal deliv-
ery pod, which was then slid proximally to exclude it from
the distal attachment system (Fig . t). Because the distal
0735409794/37.00
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Figare l
. a, The external sheath of the delivery catheter (dc) (dotted
lYes) is removed. and the metal pad (shaded) is retracted along the
length of the catheter. b, The occluding device (od), attached to the
delivery system, is loaded into the short sheath (ss). c . The short
sheath is introduced through the bleed-back (bb) device into the long
sheath (Is) positioned across the ductus . d, The device is advanced
into the long sheath. e, The short sheath is removed from the
bleed-back device and retracted along the delivery catheter . f, The
device is advanced through the long sheath for implantation .
metal pod is the largest component of the delivery system,
removal allows the use of a delivery sheath with a smaller
internal diameter . The plexiglass loader was removed front
the occluder with care taken not to remove the traction
sutures. The sutures were then reintroduced prograde
through a short 6F (12-mm device) or 8F (17-mm device)
short sheath (Cook inc.), and the device was loaded into the
sheath, with care taken to ensure properfolding of the foam .
A Mullins transseptal long sheath (Cook, Inc.) was intro-
duced transvenously across the patent ductus arteriosus for
device delivery with a bleed-back mechanism (Check-flo,
Cook Inc
.) affixed to the sheath after flushing . The occluding
device was then advanced into the long sheath by (stroduc-
ing the short sheath through the bleed-back mechanism to
the hub of the long sheath and advancing the occluder into
the long sheath. The occluder was then positioned within the
ductus, and the sheath was withdrawn over the device as
usual for implantation and release .
Statistics .
Statistical analysis was performed with the
Student r test for continuous data and by a chi-square
analysis where appropriate, and p < 0 .05 was considered
significant.
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Results
From Jur ., 1986 to November 1992,74 patients (23 male,
51 female ; mean (OSDI weight 7.9 ± 1.6 kg, range 3.98 to 10,
median 8.1 ; mean age 13 .4 } 5 .9 months, range 4 to 30,
median 13) underwent cardiac catheterization for transcath-
eter occlusion of the patent ductus arteriosus . Associated
lesions included a secundum atrial septal defect (three pa-
tients). a primum a trial septal defect with a cleft mitral valve
(one patient), pulmonary valve steeosis (one patient), com-
plete atrioventricular septal defect with restrictive ventricu-
lar component (one patient), aortic isthmal hypoplasia (one
patient) and partial anomalous pulmonary venous drainage
(one patient)
. The majority of patients were asymptomatic
with characteristic murmurs, although four patients required
diuretic therapy for pulmonary congestion .
Device implantation . The average ductal diameter was
3 .1 t 1 .2 mm (range 0.5 to 8.0). A large patent ductus
arteriosus (4 .1 t 1 .3 mm, range 2.5 to 8 .0) suitable for
closure with a l7-mm device was present in 24 patients, and
the 12-mm device was deployed for smaller ductus (2 .6 t
0.9 mm, range 0 .5 to 5 .0) in 50 patients . Fluoroscopic time
was 17 .0 t 7 .9 min (median 15, range 5 to 46). No mortality
was encountered, and no child required transfusion at cath-
eterization .
Device embolization (two 12 mm, one 17 mm) to the
pulmonary artery occurred in three of the first 15 patients .
This cccurred early in the experience and has not occurred
in the past 59 implants. All embolized devices were removed
at elective surgery.
A moderate residual shunt in one patient (7 months,
5.2 kg, 12-mm device) resulted in significant hemolytic
anemia I week after implantation . The device was surgically
removed and the ductus divided without an attempt at
transcatheter retrieval . One child (20 months, 8.7 kg, l7-mm
device) demonstrated significant compromise to left pulmo-
nary artery blood flow at the time of catheterization (Fig
.
2A). The device was uneventfully removed at catheteriza-
tion with no residual compromise .
From March 1992 to November 1992, the modification to
a downsized delivery system was utilized in eight of nine
patients weighing < 10 kg to deliver five 17-mm devices with
an BF long sheath and three 12-mm devices with a 6F (two
patients) and 7 French (one patient) long sheath . No techni-
cal difficulty in delivery resulted in using the modified
system .
Follow-up
. Of the 74 patients undergoing catheterization,
five had devices removed, leaving 69 patients with implan-
tations for follow-up study. Four patients were lost to local
follow-up, and a further 13 patients underwent occlusion <6
months before this review
. Of these 17 patients, 12 were
discharged after the procedure with no murmur, one with a
soft continuous murmur and four with soft systolic murmurs .
Follow-up ?6 months was available in all of the remaining
52 patients .
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Prevalence of residual shunting. All 7atients with a resid-
ual shunt were - jmptomatic at follow lip Table I outlines
the prevalence i a residual shunt as wel . s the auscultation
findings in the 52 patients with at least6 m-nthsof follow-up .
The prevalence of residual shunting was 33% (17 ;2) at 6
months, 20% (9 of 45) at 12 to 18 months and 17% (7 of 42)
at 24 months. No child with a continuous murmur at 6
months has demonstrated resolution of
the shunt 2 years
after implantation . At 12 to 18 months, 9 patients with a
residual leak had a slightly larger patent ductus asteriosus at
implantation, measuring 3
.4 ± 1 .4 mm compared with 2.7
0.9 mm in 36 patients with no residual shunt ; however, this
difference did not achieve statistical significance (p = 0 .18).
Implantation of a second device with elimination of the
residual defect has been accomplished in two children with
continuous murmurs at 2 years.
A comparison of the prevalence of residual shunting
between the 12- and 17-mm device at 6 . 12 to 18 and 24
months demonstrated no differences (Table 2) . Patients did
not differ by age or weight ; however, the number of patients
receiving the 17-mm device followed up to 24 months is
small, reflecting a more recent experience.
Proximal stenaela of the left pulmoany artery
. Compro-
ntise to proximal left pulmonary artery blood flow was
encountered in 7 (9.9%) of 71 successful implantations
(Table 3) . Minor increases in Doppler flow
velocity across
the proximal left pulmonary artery were noted in 2 (4.2%) of
48 patients with the 12-mm device, and more significant flow
disturbances were noted in 5 (22 .7%) of 22 patients receiving
the 17-mm device . One patient (Patient 3, Table 3) had
significant compromise in flow at catheterization, and the
device was retrieved with no sequelae
. Doppler echocardio-
graphic assessment suggested a 2
.2-mls flow velocity across
Table 1. Prevalence of Residual Shunting at Follow-Lp
6-
121 .18- 24-
Residual shunt 17152(33%) 9145(20%) 7142(17%)
Murmur 9sm,4cm,5cs
4am,3cm,2cs 4sm,3cm,Ics
Data presented are number (%) of patients. c m
= continuous murmur;
cs =
clinically silent ; sm = systolic murmur .
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Figure 2. A, Angiogram of main
pulmonary artery demonstrating
acute impaired flow to the left lung
after implantation of a 17-mm do-
vice (arrow) in a 20-month old
8 .7-kg child. Note also the right
pulmonary artery appears pletho-
ric, indicating an acute increase in
flow. B, Angiogram of main pulmo-
nary artery demonstrating proximal
left pulmonary artery stenosis 20
months after implantation of a
17-mm device (arrow).
the proximal left pulmonary artery in Patient 4, and a lung
perfusion scan demonstrated severe flow irregularity (6% to
the left lung). This child awaits recatheterization for possible
balloon angioplasty. Patient S had 30%
flow to the left lung
on perfusion scan, and at recatheterization an I8-mm Hg
gradient at the origin of the left pulmonary artery was
documented (Fig. 2B). In this child, attempted balloon
angioplasty failed. Patient 6 had a flow velocity of 3 ads at
early echocaldiographic follow-up, and a perfusion scan
demonstrated no flow to the left lung. Repeal engiography
demonstrated no filling dYhe left pulmonary artery from the
main pulmonary artery. The left pulmonary _rtery did fill by
retrograde filling from a residual shunt . This child is cur-
rently scheduled for surgical removal of the device . Patient
7, currently being followed up, has a flow velocity of 2 mls
across the left pulmonary artery origin, and a pulmonary
perfusion scan demonstrated 43% flow to the left lung . All
children with proximal left pulmonary artery stenosis remain
asymptomatic.
Dheusdm
Catheter delivery of a device for occlusion of the persis-
tently patent ductus arteriomu, first accomplished by Rash-
kind and Curaso (10) in a 3.5-kg infant, has become an
accepted management strategy in many children (1-5), and
in some centers, as an outpatient procedure, it has replaced
surgical intervention as a first line of therapy (I,S). In this
Table 2 . Prevalence of Residual Shunt by Device
Data presented are mean values ± SD or number of potions . PDA =
patent ductus aneriosus
.
12-nn Device
(n-48)
17-mm Device
In =20 pValue
Weight
(ha)
7 .9 x 1 .7 8.01 1 .5 0.78
Age (mo) 12 .5 x 6.0
13
.9 x 6.0
0.38
PDA sin (mm) 23 x 0.8 3.9 _ 1.1 0.080[
Residual shunt
6 mo 12140 5112 0.69
12-18 na 787 218
0.92
24 no 3130 217 0.17
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Table 3
. Left Pulmonary Artery Flow
	
even in those without shunt , to allow for eadothelialization
of the device . The prevalence of residual shunting of 33% at
6 months, 20% at 12 to 18 months and 17% at 24 months is
similar to that observed in older children (1). Although
residual shunting tended to Occur in patients with a larger
patent ductus arteriosus, the difference was not statistically
significant. In addition, the size of the device implanted was
not a predictor of residual shunting; however, the number of
17-mm devices with 2-year follow-up was small, A more
recent series of 205 implantation suggested that although
the larger device has a greater tendency to residual shunting
in the immediate postimplantation period, this difference is
not demonstrated at >_6 weeks
(12). In contrast, other
studies (1,5) have suggested an increased prevalence of
residual shunting associated with the '.1-mm device
. Reoc-
clusion of residual shunts associated with a continuous
,aurmur has been described elsewhere (13) and was success-
ul in these patients as well
. Because the shunt is not likely
to resolve if associated with a continuous murmur >6
months, early reocclusion appears prudent.
The endocarditis risk in patients with residual shunting in
the absence of a continuous murmur in the era of antibiotics
and improved dental hygiene is unknown. The ductal oc-
cluder is a foreign body, albeit endothelialized by 3 to 6
months in animal studies (14), so it is our practice to
continue antibiotic prophylaxis for potentially infective pro-
cedures in any child with a residual shunt demonstrated
echocardiographically .
Proximal left pulmonary artery stenosis. The most signif-
icant morbidity encountered was that due to left pulmonary
artery stenosis. Although minor disturbances of flow were
encountered it.. two patients with an implanted 12-mm de-
vice, more significant abnormalities were associated with the
17-mm device . Disturbances in flow to the left pulmonary
artery have previously been reported after transcatheter
occlusion of the patent ductus arteriosus and are not un-
known after surgical closure (1,15). Recognition of this
complication at the time of catheterization resulted in the
immediate removal of one device
. In four patients the
compromised flow was noted at follow-up and required
intervention in at least three patients . Compromise to prox-
imal left pulmonary artery flow induced by implantation of a
17-mm device represents a significant morbidity and may
preclude its use in the asymptomatic patient weighing
<10 kg. If occlLsion of the patent ductus arteriosus is
- :essary in the symptomatic small patient, p_(monary
angiography and echocardiogtaphic assessment of proximal
left pulmonary artery flow at the time of implantation of a
17-mm device is encouraged because the device can be
removed if necessary at catheterization . Our observations
with respect to left pulmonary artery blood flow were made
exclusively after device implantation . Because ductal tissue
is suspected to be involved in the genesis of left pulmonary
artery stenosis in some forms of congenital heart disease
(16), it is possible that a flow disturbance existed before the
procedure in some patients . Further prospective study is
'Device ved a1 cathetehratian, tla-mm Hg main pulmonary a,-y-
0 pulmonary artery (MPA-LPA) gradient at catheterization ; failed balloon
a-F-ptatty.
series, device implantation was technically feasible in 71 of
74 patients weighing between 3 .98 and 10 kg and was
accomplished with no death. Three device embolizations
occurred early in the experience, a recognized complication
related in part to learning the technique
(1-5)
.
The one child
with hemolytic anemia underwent surgical closure without
an attempt at catheter removal and reocclusion with a
second device . Hemolysis associated with a residual leak is
a rare but recognized complication that can resolve with time
or elimination of the shunt (5
.1 1).
Modified delivery system. In 1984, the introduction of the
long sheath technique for safe, ,renteolled transvenous de-
livery of the occluder allowed the procedure to be applied
without insult to the femoral artery (3). A limitation of this
approach has been the difficulty in using an 8F internal
diameter sheath in the small child <6 kg and the I I F sheath
in the child <10 to 15 kg (3,4,12) . Recently a method for
loading the device into the long sheath has been described
that allows the occluder to be inserted into a sheath smaller
by one French size (6). In this approach the device is first
loaded into the metal delivery pod for introduction into a
modified end of a long sheath. However, manipulation of the
sheath and delivery of the device without the use of a
bleed-back mechanism may have accounted for the require-
ment for blood transfusion in 7 of 17 patients. By first loading
the device into a short sheath, we eliminated the need for
modifying the long sheath to accept the device and have
effectively reduced the size of the delivery sheath of the
17-mm device from I IF to SF and that of the 12-mm device
from SF to 6F or 7F
. The use
of
a bleed-back system on the
long sheath reduces or eliminates blood loss . Although using
a smaller internal diameter system has an obvious advantage
in the small child, trauma to the accessed vessel is reduced
even in the older child .
Prevalence o f residual ahLnting, Immediate aortography
or echocardiographic screening for residual shunting imme-
diately after implantation was not routinely performed be-
cause prevalence continues to decline rapidly over the Ist 6
months (1,5,12) . It is our practice to continue antibiotic
prophylaxis in all patients pending the results of follow-up
clinical and echocardiographic examination at 6 months,
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Pt No.1
Dander
Device
(mml
Weigh)
(kill
Doppler Velocity
MPA-LPA
(MS)
Nuclear Lung
Scan
I/F 12 8.1 1 .8 397/ ten
2/F
12 8.8 1.8 -
3/M' 17 8.7 - -
4/M 17 7.9
2. 2
621en
5/Mt
17
7A 2.8 3r, I'll
am
17 4 .7
3 .0 a, lea
TIM
17
7 .0
2 .0 437/ lea
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warranted to investigate the nature of the flow disturbance
before and after implantation, its incidence in the larger child
and the association, if any, with surgical interventions, A
potential modification of the device with a 12-mm proximal
disk and a 17-mm distal or aortic disk should be considered.
Concluslons. Device occlusion of the persistently patent
ductus arteriosus in the small child
<10 kg is technically
feasible and can be accomplished at low risk with no
mortality. The delivery system can be modified for safe
delivery using a 6F or
8F long sheath, reducing vessel
trauma and allowing application to other cardiovascular
defects (6,7,17)
. The prevalence of residual shunting is
similar to that experienced by older patients . Because im-
plantation
of
the larger device has resulted in compromised
blood flow to the left lung, elective occlusion of the ductus
where a large device may be required should be closely
monitored and, in the very small child, perhaps avoided . If
occlusion is necessary in the symptomatic pationt, implan-
tation should be followed immediately with angography and
echocardiographic assessment to assess left pulmonary ar-
tery flow and the device removed
if
a significant abnormality
is demonstrated
.
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